Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


LSP’s portfolio company Curetis raises EUR 40 million in successful Euronext IPO.


Amsterdam, the Netherlands - 12 November 2015 - Our portfolio company Curetis N.V., a developer of advanced molecular diagnostic assays for severe infectious diseases in hospitalized patients, raised € 40 million in an initial public offering (IPO) through a listing in Euronext Amsterdam and Euronext Brussels. LSP has led the Series A financing of Curetis in 2009 and supported the company in further financings in subsequent years and in the IPO process. For LSP’s Health Economics Fund it is the first of its portfolio companies that becomes listed on the stock market. We are very happy that our portfolio company Curetis is one of a very few European medtech companies that successfully achieved a listing on Euronext this year. A version of the company’s press release can be found here.

About LSP
LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing for private and public life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With over EUR 1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors. For more information, please visit lspvc.com

We are looking forward to keeping you informed about further news.

Dr Jörg Neermann, Partner LSP
jneermann@lspvc.com
Tel: +49 (89) 330 6660
lspvc.com

Dr. Rudy Dekeyser, Managing Partner LSP Health Economics Fund
rdekeyser@lspvc.com
Tel: +31 (20) 664 55 00
Lspvc.com


Publisher Contact Information:

Life Sciences Partners (LSP)
+31 (20) 664 55 00
rdekeyser@lspvc.com

Company profile of Life Sciences Partners (LSP)
Past press releases of Life Sciences Partners (LSP).

Data


24,987
Tech investments
From our Online Data Service
16,172
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Nov 16€0.8MMedical devices
Nov 16N/AInternet services
Nov 16€15.0MPayment software
Nov 15€5.0MInternet services
Nov 15€66.0MSemiconductors
Nov 15N/ABusiness applications
Nov 15€25.0MArtificial Intelligence

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...

Aug 17
Komed Health
komed health closes seed financing round

Jul 10
Komed Health
komed health to be supported by nokia and deutsche telekom





About usContact usLegal Information
Copyright © 1999-2018
Emerging Technology Research Europe Inc. All rights reserved.